Duke Energy Shorts Build as Analysts Cut Targets

The Street has been consistently cutting targets, and that is the more telling story heading into the print. Multiple analysts trimmed price objectives this week alone. JP Morgan's Jeremy Tonet lowered his target to $130 from $137, maintaining a Neutral rating. Keybanc's Sophie Karp cut to $128 from $139, keeping an Overweight. Truist Securities moved to $130 from $135, also Buy-rated. Barclays dropped to $124 last week. The direction is unmistakably one-way: every recent change in the data is a reduction, with no upgrades or initiations in the recent window. The consensus mean target of $134 still implies around 13% upside from the current $118.19, but that gap has been narrowing steadily. Bull case arguments centre on above 6.5% annual EPS growth, planned capital expenditure increases from the Carolinas Resource Plan, and roughly 2% population growth in the company's core service territories. The bear case points to dividend growth running at only about 2% annually, well below the utility sector average of around 5.5%, limiting the stock's appeal against income-oriented peers.

Factor positioning reflects that ambivalence. The dividend score ranks in the 81st percentile, consistent with Duke's yield-focused investor base. But EPS momentum looks soft, ranking in the 37th to 40th percentile on both 30-day and 90-day horizons, and the 12-month forward earnings growth estimate is negative year-on-year, a meaningful drag on the growth component. The ORTEX short score has crept up from around 35 to 36.4 over the past two weeks, a modest but directional move that tracks the rise in short positioning. Valuation multiples are largely steady, with the P/E at 16.7 and EV/EBITDA at 10.3, neither of which has moved materially in the past month.

One data point worth noting from the ORTEX Alt Data layer: the Nuclear Regulatory Commission reactor status series for Duke is recording an output reading that was flagged at a z-score of minus 10 relative to the unit's own trailing history as of mid-September, an extreme deviation consistent with outage activity. The dataset has not yet accumulated enough history to be tested as a leading indicator for Duke's revenue, so no inference about the upcoming print should be drawn. It is, however, a real operational signal worth tracking as the Q3 earnings date approaches.

Institutional ownership is stable. BlackRock holds around 9% and has been adding modestly. State Street and Geode have also been adding small increments. A Vanguard Group filing from March disclosed a reduction to zero from a prior 10% stake, though a separate Vanguard Capital Management entity filed in April carrying a 7.54% holding, suggesting a reclassification or entity-level reorganisation rather than a genuine exit. No 13D activist is on the register. Insider activity since May has been limited and mixed: the CEO sold 20,000 shares in early May at $124.37, a discretionary sale at the time the stock was closer to its recent highs, while director grants in the same period were routine compensation awards carrying no signal weight.

With Q3 results due on November 5, the question for the next three weeks is whether the nuclear output anomaly resolves, whether the steady drip of target cuts slows, and whether the short build continues at the October pace or plateaus now that the stock has pulled around 1% below its one-month level.